Furthermore, recent studies have highlighted beneficial roles of PPARγ agonists for patients with chronic renal failure, hemodialysis, as well as peritoneal dialysis (PD) could also benefit from [99, 100]. The gene discussed is PPARG; the disease is chronic kidney disease.